Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × Bupivacaine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 25 Breast Neoplasms 21 Lung Neoplasms 10 Pain 9 Agnosia 9 Leiomyoma 6 Pancreatic Neoplasms 5 Neoplasms 5 Colorectal Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neuralgia 3 Hot Flashes 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Neuroma 2 Kidney Neoplasms 2 Ileus 2 Hyperparathyroidism 2 Goiter 2 Digestive System Diseases 2 Colonic Neoplasms 2 Chronic Pain 2 Breast Cancer Female 2 Brain Neoplasms 2 Abdominal Cancer 2 post laminectomy syndrome 1 Vesico-Ureteral Reflux 1 Uterine Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Blood Specimen Collection 8 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Prednisone 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 weifuchun 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Gemcitabine 2 Dexamethasone 2 Dermoscopy 2 Cyclophosphamide 2 Clinical Laboratory Techniques 2 vistusertib 1 venetoclax 1 tivozanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07254650 2025-11-28

CALMS-1

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting

Agnosia, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡